Published in Mov Disord on January 01, 1997
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry (2002) 2.66
Is electrical stimulation beneficial for improving the paralytic effect of botulinum toxin type A in children with spastic diplegic cerebral palsy? Yonsei Med J (2008) 0.83
High-frequency, low-magnitude vibration does not prevent bone loss resulting from muscle disuse in mice following botulinum toxin injection. PLoS One (2012) 0.83
Targeted secretion inhibitors-innovative protein therapeutics. Toxins (Basel) (2010) 0.83
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine. Neuropsychiatr Dis Treat (2012) 0.82
Effect of the refrigerator storage time on the potency of botox for human extensor digitorum brevis muscle paralysis. J Clin Neurol (2013) 0.75
Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia. J Neural Transm (Vienna) (2014) 0.75
Assessing the immediate impact of botulinum toxin injection on impedance of spastic muscle. Med Eng Phys (2017) 0.75
Vocal exercise versus voice rest following botulinum toxin injections: a randomized crossover trial. Ann Otol Rhinol Laryngol (2009) 0.75
Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them. Toxicon (2015) 0.75
Surface mechanomyogram reflects muscle fibres twitches summation. J Biomech (1996) 1.97
The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A. Clin Auton Res (2002) 1.51
Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology. Ital J Neurol Sci (1997) 1.46
Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies. Neurology (2004) 1.41
Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci Lett (1998) 1.08
Is Ross syndrome a dysautonomic disorder only? An electrophysiologic and histologic study. Clin Neurophysiol (2003) 1.04
Visual evoked potentials in diabetic children and adolescents. Diabetes Care (1984) 1.02
A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1. Neuroscience (2008) 1.02
Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Brain (2004) 1.02
Entrapment of the suprascapular nerve at the spinoglenoid notch. Ann Neurol (1982) 1.00
Vibrational, 1H-NMR spectroscopic, and thermal characterization of gladiolus root exudates in relation to Fusarium oxysporum f. sp. gladioli resistance. Biopolymers (2002) 0.98
Botulinum neurotoxins: mechanism of action and therapeutic applications. Mol Med Today (1996) 0.95
Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human. Neurosci Lett (1997) 0.94
Metabolic findings on 3T 1H-MR spectroscopy in peritumoral brain edema. AJNR Am J Neuroradiol (2007) 0.94
Explosive-aggressive behavior related to bilateral subthalamic stimulation. Parkinsonism Relat Disord (2004) 0.93
Management of parotid sialocele with botulinum toxin. Laryngoscope (1999) 0.92
Molecular characterization of human healthy and neoplastic cerebral and renal tissues by in vitro (1)H NMR spectroscopy (review). Int J Mol Med (2002) 0.91
Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis. Br J Dermatol (2002) 0.91
Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression. J Med Genet (1998) 0.90
The influence of muscular lengthening on cramps. Ann Neurol (1993) 0.90
Sporadic adult onset distal myopathy. J Neurol Neurosurg Psychiatry (1987) 0.87
Two Italian patients with novel AAAS gene mutation expand allelic and phenotypic spectrum of triple A (Allgrove) syndrome. Clin Genet (2010) 0.87
Lower-limb lengthening in short stature. An electrophysiological and clinical assessment of peripheral nerve function. J Bone Joint Surg Br (1997) 0.85
High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm. Neurol Sci (2006) 0.84
Pattern electroretinogram in multiple sclerosis. J Neurol Neurosurg Psychiatry (1984) 0.84
The post-auricular response. A single motor unit study. Electroencephalogr Clin Neurophysiol (1980) 0.84
Treatment of Frey syndrome with botulinum toxin type F. Arch Otolaryngol Head Neck Surg (2001) 0.84
ALS and myasthenia: An unusual association in a patient treated with riluzole. Muscle Nerve (2000) 0.83
Static vestibulospinal influences in relation to different body tilts in man. Exp Neurol (1983) 0.83
Neurological involvement in primary Sjögren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheumatol (1999) 0.83
Polyneuritis cranialis: clinical and electrophysiological findings. J Neurol Neurosurg Psychiatry (1992) 0.83
Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F. Neurotox Res (2006) 0.83
Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients. J Neural Transm (Vienna) (2014) 0.83
The electromyographic examination of the posterior auricular muscle. Electromyogr Clin Neurophysiol (1986) 0.82
Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group. Ital J Neurol Sci (1993) 0.82
Cholesteryl esters in human malignant neoplasms. Int J Mol Med (2003) 0.82
Hypokalemic periodic paralysis. A single fiber electromyographic study. J Neurol Sci (1978) 0.81
Neurophysiological study of corticomotor pathways in restless legs syndrome. Clin Neurophysiol (2003) 0.81
Magnetic resonance spectroscopy and chromatographic methods identify altered lipid composition in human renal neoplasms. Int J Mol Med (2004) 0.81
A patient with limb girdle muscular dystrophy carries a TRIM32 deletion, detected by a novel CGH array, in compound heterozygosis with a nonsense mutation. Neuromuscul Disord (2013) 0.81
Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion. Neurology (1996) 0.81
Hypoglossal vertebral entrapment syndrome. Muscle Nerve (1999) 0.81
The auxin-like activity of humic substances is related to membrane interactions in carrot cell cultures. J Chem Ecol (2007) 0.80
Motor evoked responses to paired cortical magnetic stimulation in Parkinson's disease. Electroencephalogr Clin Neurophysiol (1997) 0.80
Spinal anesthesia and minimal invasive laminotomy for paddle electrode placement in spinal cord stimulation: technical report and clinical results at long-term followup. ScientificWorldJournal (2012) 0.80
[Peripheral neuropathy caused by incongruous posture in shoe manufacture workers]. Med Lav (1989) 0.80
In vivo single voxel 1H MRS of glial brain tumors: correlation with tissue histology and in vitro MRS. Int J Oncol (1998) 0.80
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up. Neurol Sci (2011) 0.79
On the action of botulinum neurotoxins A and E at cholinergic terminals. J Physiol Paris (1998) 0.79
Recovery cycle of the masseter inhibitory reflex after magnetic stimulation in normal subjects. Clin Neurophysiol (2003) 0.78
Spinal somatosensory evoked potentials in patients with tethered cord syndrome. Can J Neurol Sci (1994) 0.78
n-hexane polyneuropathy. An occupational disease of shoemakers. Eur Neurol (1980) 0.78
Reynaud's phenomenon and entrapment neuropathies. Ann Neurol (1985) 0.78
Far-field and cortical somatosensory evoked potentials in motor neuron disease. Muscle Nerve (1990) 0.77
Sympathetic skin response in patients with Duchenne muscular dystrophy. Electromyogr Clin Neurophysiol (1995) 0.77
Botulinum toxin treatment of muscle cramps: a clinical and neurophysiological study. Ann Neurol (1997) 0.77
Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? Biomarkers (2006) 0.77
High-performance liquid chromatographic analysis of physiological amino acids in human brain tumors by pre-column derivatization with phenylisothiocyanate. J Chromatogr B Biomed Sci Appl (1999) 0.77
Early MR imaging and spectroscopy appearance of eIF2B-related leukoencephalopathy. Neurology (2006) 0.77
Carnitine kinetics during dialysis. Evidence of unilateral transport from tissues to plasma. Nephron (1985) 0.77
An experimental study on the neurotoxicity of n-hexane metabolites: hexanol-1 and hexanol-2. Toxicol Appl Pharmacol (1978) 0.77
Idiopathic facial paralysis: new therapeutic prospects with acetyl-L-carnitine. Int J Clin Pharmacol Res (1992) 0.77
In vivo and in vitro nuclear magnetic resonance spectroscopy investigation of an intracranial mass. Oncol Rep (2001) 0.77
Effect of slow rTMS of motor cortex on the excitability of the blink reflex: a study in healthy humans. Clin Neurophysiol (2008) 0.76
Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study. J Peripher Nerv Syst (1996) 0.76
The therapeutic use of botulinum toxin. Expert Opin Investig Drugs (1997) 0.76
Fibrillatory activity and other membrane changes in partially denervated muscles. Muscle Nerve (1989) 0.76
Time and frequency domain analysis of surface myoelectric signals during electrically-elicited cramps. Neurophysiol Clin (2008) 0.76
Nitrogen-15 NMR characterization of the neutral form of 7-methylguanosine. Nucleic Acids Res (1988) 0.75
[Retinal oscillatory potentials in the study of retinopathy in dialyzed subjects with chronic renal insufficiency]. Riv Neurol (1991) 0.75
Neurophysiological evaluation of the muscular hypotrophy after immobilization. Electromyogr Clin Neurophysiol (1989) 0.75
[Analysis of conduction in somatosensory pathways in man]. Boll Soc Ital Biol Sper (1985) 0.75
[The origin of the electroretinogram induced by structured stimuli in man]. Boll Soc Ital Biol Sper (1984) 0.75
Pattern of motor evoked response to repetitive transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol (1994) 0.75
Assessment of autonomic functions in insulin-dependent diabetic children and adolescents. Funct Neurol (1988) 0.75
Carcinogenic and anticarcinogenic substances and nucleic acid constituents: their interaction mechanism by Raman, IR, and NMR spectroscopy. Biochem Pharmacol (1988) 0.75
[Home artificial ventilation--follow-up of 10 patients]. Minerva Anestesiol (1990) 0.75
[The conduction of optic nerve fibers using different visual patterns]. Boll Soc Ital Biol Sper (1984) 0.75
An electroneurographic response. Muscle Nerve (1986) 0.75
Transitory L-carnitine depletion in rat skeletal muscle by D-carnitine. Pharmacol Res (1989) 0.75
Variability of tibial nerve early cortical potentials in normal subjects. Electromyogr Clin Neurophysiol (1994) 0.75
[Quantitative analysis of central and peripheral acoustic pathway conduction in man]. Boll Soc Ital Biol Sper (1986) 0.75
Chronic alcoholic and corticosteroid myopathy. Lancet (1977) 0.75
Congenital muscular dystrophy and cerebellar vermis agenesis in two brothers. Ital J Neurol Sci (1988) 0.75
Peripheral neuropathy as a manifestation of hydatid disease. A case report. Acta Neurol (Napoli) (1987) 0.75
Molecular interactions between nucleic acids and antitumor substances by Raman and NMR spectroscopy. Anticancer Res (1987) 0.75
[The effect of thoracic pressoreceptors on heart rate in man]. Boll Soc Ital Biol Sper (1984) 0.75
Local neurotoxicity of cisplatin after intra-arterial chemotherapy. Acta Neurol Scand (1986) 0.75
[Quantitative analysis of the P300 wave in a normal population]. Boll Soc Ital Biol Sper (1987) 0.75
"Double crush" mechanism impairing a nerve revealed by studies of the motor axon reflex and M wave terminal phase. A case report. Acta Neurol (Napoli) (1984) 0.75